Does XARELTO Cause Pericardial effusion? 20 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Pericardial effusion have been filed in association with XARELTO. This represents 0.6% of all adverse event reports for XARELTO.
20
Reports of Pericardial effusion with XARELTO
0.6%
of all XARELTO reports
3
Deaths
7
Hospitalizations
How Dangerous Is Pericardial effusion From XARELTO?
Of the 20 reports, 3 (15.0%) resulted in death, 7 (35.0%) required hospitalization, and 3 (15.0%) were considered life-threatening.
Is Pericardial effusion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for XARELTO. However, 20 reports have been filed with the FAERS database.
What Other Side Effects Does XARELTO Cause?
Pulmonary embolism (276)
Deep vein thrombosis (234)
Drug ineffective (199)
Gastrointestinal haemorrhage (198)
Cerebrovascular accident (180)
Haemoglobin decreased (166)
Fall (124)
Anaemia (123)
Haemorrhage (121)
Cerebral haemorrhage (110)
What Other Drugs Cause Pericardial effusion?
TREPROSTINIL (584)
IBRUTINIB (467)
CYCLOPHOSPHAMIDE (458)
NIVOLUMAB (454)
METHOTREXATE (412)
MACITENTAN (407)
DASATINIB (388)
ADALIMUMAB (374)
AMBRISENTAN (371)
PEMBROLIZUMAB (362)